0001529349-25-000001.txt : 20250428 0001529349-25-000001.hdr.sgml : 20250428 20250425214127 ACCESSION NUMBER: 0001529349-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250428 DATE AS OF CHANGE: 20250425 EFFECTIVENESS DATE: 20250428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abrexa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001529349 ORGANIZATION NAME: EIN: 453074039 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-544571 FILM NUMBER: 25875787 BUSINESS ADDRESS: STREET 1: 1282 UPAS STREET CITY: SAN DIEGO STATE: CA ZIP: 92103 BUSINESS PHONE: (619) 295-5077 MAIL ADDRESS: STREET 1: 1282 UPAS STREET CITY: SAN DIEGO STATE: CA ZIP: 92103 D 1 primary_doc.xml X0708 D LIVE 0001529349 Abrexa Pharmaceuticals, Inc. 402 W Broadway Suite 400 SAN DIEGO CA CALIFORNIA 92101 (619) 295-5077 DELAWARE None None Corporation true J. Ernest Villafranca 402 W Broadway Suite 400 San Diego CA CALIFORNIA 92101 Executive Officer Director James J. Truchard 402 W Broadway Suite 400 San Diego CA CALIFORNIA 92101 Director David Hughley 402 W Broadway Suite 400 San Diego CA CALIFORNIA 92101 Director Other Health Care Decline to Disclose 06b false 2025-04-10 false true false 0 22999999 22999999 0 false 2 0 0 0 false Abrexa Pharmaceuticals, Inc. J. Ernest Villafranca J. Ernest Villafranca Chief Executive Officer 2025-04-24